Deoxyribonucleoside kinases activate nucleoside antibiotics in severely pathogenic bacteria
Michael P B Sandrini1, Oonagh Shannon, Anders R Clausen
1Department of Molecular Biology, University of Copenhagen, Universitetsparken 13, Copenhagen, Denmark. msandrini@aki.ku.dk
Pyrimidine nucleoside analogs, like gemcitabine, show promise as novel antibiotics. Bacterial kinases activate these compounds, leading to pathogen cell death and protection in animal models against deadly infections.
Area of Science:
- Microbiology
- Drug Discovery
- Biochemistry
Background:
- Antibiotic resistance in common bacterial pathogens poses a significant public health threat.
- Novel antibiotics with alternative mechanisms of action are urgently needed.
- Nucleoside analogs are a potential class of antimicrobial agents.
Purpose of the Study:
- To investigate the efficacy of pyrimidine-based nucleoside analogs against pathogenic bacteria.
- To elucidate the activation mechanism of nucleoside analogs by bacterial enzymes.
- To evaluate the therapeutic potential of gemcitabine in a preclinical bacterial infection model.
Main Methods:
- Testing pyrimidine nucleoside analogs against Staphylococcus and Streptococcus species.
- Assessing the role of bacterial deoxyribonucleoside kinases in nucleoside analog activation using engineered E. coli strains.
- In vitro enzymatic assays using recombinant Staphylococcus aureus deoxyadenosine kinase.
- Evaluating gemcitabine efficacy in a mouse model of Streptococcus pyogenes infection.
Main Results:
- Pyrimidine nucleoside analogs, including 3'-azido-3'-deoxythymidine (AZT) and gemcitabine, were activated by bacterial deoxyribonucleoside kinases, leading to bacterial cell death.
- Deoxyribonucleoside kinase-deficient E. coli became susceptible to nucleoside analogs upon expression of recombinant kinases from S. aureus or S. pyogenes.
- Recombinant S. aureus deoxyadenosine kinase efficiently phosphorylated gemcitabine in vitro, identifying it as a key enzyme in the activation pathway.
- Gemcitabine administration protected mice from a fatal S. pyogenes infection.
Conclusions:
- Bacterial deoxyribonucleoside kinases are crucial for activating pyrimidine nucleoside analogs.
- Gemcitabine, activated by bacterial kinases, demonstrates potent antimicrobial activity and therapeutic efficacy in vivo.
- Nucleoside analogs represent a promising new avenue for developing antibiotics against resistant bacterial pathogens.
More Related Videos
08:46Regioselective O-Glycosylation of Nucleosides via the Temporary 2',3'-Diol Protection by a Boronic Ester for the Synthesis of Disaccharide Nucleosides
Published on: July 26, 2018
08:17A High-Throughput Enzyme-Coupled Activity Assay to Probe Small Molecule Interaction with the dNTPase SAMHD1
Published on: April 16, 2021
Related Concept Videos
Antiviral Nucleoside Inhibitors
Types of RNA
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Inhibitors of Bacterial DNA Synthesis
Inhibitors of Bacterial Protein Synthesis
Biosynthesis of Nucleic Acids
Inhibitors of Viral Protein Synthesis
